EL7.AI
StocksMedium•19 November 2026•
3 min read

Vivid Seats’ recapitalization and debt reduction agreement on November 19 could not be confirmed

Key Facts

1Gross order value was $624.0 million, revenue was $126.9 million, and net loss was $17.4 million in the third quarter of 2026.
2The initial proposal announced on November 9 envisioned $60 million in new loans and a reduction of about $200 million in funded debt.
3The outstanding first-lien term loan balance was $387.129 million on September 30, 2026.
4The company maintained its 2026 guidance at $2.3 billion to $2.6 billion for gross order value and $34.0 million to $40.0 million for adjusted EBITDA.

In its results statement issued on November 9, the company disclosed a preliminary agreement with a group of lenders, not the terms of a subsequent agreement. The proposal at the time envisioned $60 million in new loans and the conversion of a large portion of existing debt into equity. It also aimed to reduce total funded debt by about $200 million and extend the maturity of the remaining debt. The company said the proposal was conditional on negotiating and executing definitive documents. Details of the announcement attributed to November 19 therefore remain unconfirmed, while the November 9 disclosures provide earlier context for the recapitalization discussions.

This context follows a quarter in which the company recorded gross order value of $624.0 million and revenue of $126.9 million. Net loss was $17.4 million in the third quarter of 2026. Adjusted EBITDA, meanwhile, reached $8.9 million. Year over year, gross order value rose to $623.988 million from $618.139 million in the corresponding quarter of 2025. Adjusted EBITDA also increased to $8.865 million from $4.905 million in the comparable period. CEO Lawrence Fey attributed the return to annual growth in order value and adjusted EBITDA to the company’s continued execution of its strategic priorities.

Third-quarter data show that the outstanding first-lien term loan stood at $387.129 million on September 30, 2026. The company had refinanced the balance on February 5, 2025, with a $393.0 million term loan. The disclosure set the loan’s maturity at February 3, 2029. That is the maturity disclosed previously; an extension to 2032 under the agreement attributed to November 19 cannot be confirmed. In its initial announcement, the company said the proposed recapitalization was intended to strengthen the balance sheet and enhance liquidity and financial flexibility. According to the statement, the proposal remained subject to completion of negotiations over, and execution of, definitive documents.

In its November 9 statement, Vivid Seats maintained its 2026 guidance at a range of $2.3 billion to $2.6 billion for gross order value. It also maintained its adjusted EBITDA range of $34.0 million to $40.0 million. This guidance is for the year ending December 31, 2026, and was issued alongside the results and initial proposal. It is not an update accompanying the agreement attributed to November 19. In premarket trading on November 9, the stock rose 3.35% to $2.16 from $2.09, alongside the results and initial proposal announcement. That move relates to the earlier announcement session and does not indicate the market’s response to the news attributed to November 19.

Open on chart